Gk. Marathe et al., MEDIATION BY PROSTAGLANDINS OF THE STIMULATORY EFFECT OF SUBSTANCE-P ON CYCLIC-AMP PRODUCTION IN DOG IRIS SPHINCTER SMOOTH-MUSCLE, Biochemical pharmacology, 52(8), 1996, pp. 1261-1269
The purpose of the present study was to examine the mechanism of the s
timulatory effect of substance P (SP) on cyclic AMP (cAMP) accumulatio
n in dog iris sphincter. We found that: (1) SP increased cAMP accumula
tion in a time- and concentration-dependent manner, the T-1/2 and EC(5
0) values being 1.2 min and 44 nM, respectively. SP has no effect on i
nositol trisphosphate and muscle contraction in this tissue. (2) SP-st
imulated cAMP formation was inhibited by quinacrine, a non-specific ph
ospholipase A(2) inhibitor (IC50 = 9.5 mu M), and by indomethacin (Ind
o), a cyclooxygenase inhibitor (IC50 = 3.5 nM), in a concentration-dep
endent manner, suggesting that SP induces cAMP accumulation via an Ind
o-sensitive pathway. (3) SP-induced arachidonic acid release and SP-in
duced prostaglandin E(2) (PGE(2)) release were inhibited concentration
dependently by quinacrine and Indo, with IC50 values of 11 mu M and 0
.8 nM, respectively. (4) PGE(2) (1 mu M) increased cAMP formation in t
he sphincter muscle by 94%, and, furthermore, the PG, but not SP, stim
ulated the activity of adenylyl cyclase in membrane fractions isolated
from this tissue. (5) Indo (1 mu M) blocked the relaxing effect of SP
(1 mu M) in iris sphincter precontracted with carbachol (1 mu M). (6)
The inhibitory effect of Indo on SP-induced cAMP accumulation was spe
cies specific. Increases in cAMP represent a mechanism by which extrac
ellular SP can regulate smooth muscle function. Thus, we conclude from
these studies that in dog iris sphincter SP-induced cAMP accumulation
is mediated through PGs, and that in this cholinergically innervated
muscle SP via cAMP could function, in part, to modulate the physiologi
cal responses to muscarinic receptor stimulation.